• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Pharmaceutical Manufacturing in the U.S. Product Image

Pharmaceutical Manufacturing in the U.S.

  • ID: 1052550
  • September 2014
  • Region: United States
  • 10 pages
  • First Research

Brief Excerpt from Industry Overview Chapter:

Companies in this industry manufacture and process pharmaceutical products. Major companies include Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, Merck & Co, and Pfizer (all based in the US), as well as AstraZeneca (UK), Bayer (Germany), GlaxoSmithKline (UK), Novartis (Switzerland), Roche Holding (Switzerland), and Sanofi (France).

The global pharmaceutical manufacturing industry generates more than $1 trillion in annual revenue. Worldwide spending on medicines is increasing due to economic growth in developing nations and the rising cost of specialty drugs. The US and the EU remain the largest importers of pharmaceuticals, but manufacturers are targeting emerging economies for growth. Key growth opportunities include Brazil, China, India, and Russia (the BRIC nations).

The US pharmaceutical manufacturing industry includes about 2,200 establishments (single-location companies and units of multi-location companies) with combined annual revenue of about $200 billion.

COMPETITIVE LANDSCAPE

Demand for pharmaceuticals is driven by the desire to cure illness and disease. The profitability of individual READ MORE >

Industry Overview
Quarterly Industry Update
Business Challenges
Business Trends
Industry Opportunities
Call Preparation Questions
Financial Information
Industry Forecast
Web Links and Acronyms

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos